Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media—#MPNSM

Purpose of reviewThe use of social media has now become a standard means of communication for many individuals worldwide. The use of one specific form of social media, Twitter, has increased among healthcare providers, both as a means of information gathering and as a conduit for original content creation. Recently, major efforts by users have been put forward to help streamline the unprecedented amount of information that can be found on Twitter. These efforts have led to the creation of diseasespecific hashtag (#) medical communities and have greatly enhanced the ability to understand and better categorize the available data on Twitter. Specifically, for those involved in rare cancer fields, adhering to organically designed and consistently used hashtags has led to the rapid, reliable dissemination of information and the ability to efficiently discuss and debate topics of interest in the field. For the field of myeloproliferative neoplasms (MPNs), the creation of #MPNSM (myeloproliferative neoplasms on social media) in 2015 has facilitated interactions among healthcare stakeholders from all over the world in the MPN field.Recent findingsIn order to better understand the trends and topics of interest to Twitter users of this novel medical community, we conducted the present analysis which focuses on Twitter analytics from the first two years of #MPNSM.SummaryIn this analysis, we observed a sustained increase in the number of Twitter users, number of tweets, number of impressions, and number of retweets over time, demonstrating the feasibility of creating and maintaining a disease-specific hashtag for a rare cancer over time.

[1]  Tejas Desai,et al.  Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends. , 2017, Journal of oncology practice.

[2]  R. Mesa,et al.  Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM , 2016, Current Hematologic Malignancy Reports.

[3]  D. Asch,et al.  Twitter as a Potential Data Source for Cardiovascular Disease Research. , 2016, JAMA cardiology.

[4]  A. Lane,et al.  Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) , 2016, Current Hematologic Malignancy Reports.

[5]  Robert S. Miller,et al.  Using social media in oncology for education and patient engagement. , 2012, Oncology.

[6]  R. Mesa,et al.  The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette. , 2017, Seminars in hematology.

[7]  M. Markham,et al.  Social Media for Networking, Professional Development, and Patient Engagement. , 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[8]  W. Wood,et al.  Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer , 2016, Current Hematologic Malignancy Reports.

[9]  M. Thompson Using social media to learn and communicate: it is not about the tweet. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[10]  Twitter 101 and beyond: introduction to social media platforms available to practicing hematologist/oncologists. , 2017, Seminars in hematology.

[11]  Naveen Pemmaraju,et al.  Disease-specific hashtags and the creation of Twitter medical communities in hematology and oncology. , 2017, Seminars in hematology.

[12]  D. Murphy,et al.  Activity, content, contributors, and influencers of the twitter discussion on urologic oncology. , 2016, Urologic oncology.

[13]  W. Wood,et al.  Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider , 2015, Current Hematologic Malignancy Reports.

[14]  P. F. Anderson,et al.  Disease-Specific Hashtags for Online Communication About Cancer Care. , 2016, JAMA oncology.

[15]  R. Mesa,et al.  Social Media and Myeloproliferative Neoplasms (MPN)—Focus on Twitter and the Development of a Disease-specific Community: #MPNSM , 2015, Current Hematologic Malignancy Reports.

[16]  Sean Ekins,et al.  Ten Simple Rules of Live Tweeting at Scientific Conferences , 2014, PLoS Comput. Biol..

[17]  N. Savage Scientists in the Twitterverse , 2015, Cell.

[18]  Raina M Merchant,et al.  Cancer Communication in the Social Media Age. , 2016, JAMA oncology.

[19]  Aafia Chaudhry,et al.  Trends in twitter use by physicians at the american society of clinical oncology annual meeting, 2010 and 2011. , 2012, Journal of oncology practice.

[20]  A. Nazha,et al.  Impact of social media for the hematologist/oncologist. , 2017, Seminars in hematology.

[21]  Robert S. Miller,et al.  Practical guidance: the use of social media in oncology practice. , 2012, Journal of oncology practice.

[22]  The emerging role of professional social media use in oncology. , 2017, Future oncology.